{"title":"Sciatic Nerve Regeneration in Rat Model With PLGA-MWCNT Conduit Loaded by Fibrin Hydrogel Containing Nanolycopene and Schwann Cells","authors":"Jafar Ai, Majid Salehi, Shima Shojaie, Tahmineh Jazdani, Arian Ehterami, Sepehr Zamani, Mozhdeh Salehi Namini, Farzaneh Torabi Mehr, Ali Farzin, Fariborz Sharifianjazi, Kourosh Mansoori, Hossein Kargar Jahromi","doi":"10.1002/jbm.b.35643","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>This study developed a biodegradable neural guidance conduit using electrospun poly(lactic-co-glycolic acid) (PLGA) and multiwall carbon nanotubes (MWCNT) to deliver allogeneic Schwann cells (SCs) for enhanced peripheral nerve regeneration. The conduit incorporated fibrin and lycopene-chitosan nanoparticles (Lyco-CNPs) optimized for enhanced stability and drug delivery (diameter: 163 ± 6 nm; zeta potential: −9.3 mV), addressing limitations of prior formulations. Key structural and mechanical properties included a fiber diameter of 251 ± 22 nm, tensile strength of 5.86 ± 0.98 MPa, Young's modulus of 1.68 ± 0.25 MPa, and pore diameter of 21.8 nm, ensuring robustness and nutrient diffusion. In vitro studies confirmed a dose-dependent increase in Schwann cell proliferation via MTT assay with the addition of lycopene nanoparticles (NL). In a 10-mm sciatic nerve defect model in rats, the PLGA-CNT-nanoLyco conduit seeded with SCs demonstrated superior regeneration, evidenced by 35.31% higher myelinated nerve density compared to controls. Histopathological (hematoxylin–eosin/Luxol fast blue) and walking-footprint analysis confirmed enhanced axonal alignment and remyelination. These results highlight the conduit's dual functionality as a structural scaffold and bioactive delivery system for nerve repair.</p>\n </div>","PeriodicalId":15269,"journal":{"name":"Journal of biomedical materials research. Part B, Applied biomaterials","volume":"113 9","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part B, Applied biomaterials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35643","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
This study developed a biodegradable neural guidance conduit using electrospun poly(lactic-co-glycolic acid) (PLGA) and multiwall carbon nanotubes (MWCNT) to deliver allogeneic Schwann cells (SCs) for enhanced peripheral nerve regeneration. The conduit incorporated fibrin and lycopene-chitosan nanoparticles (Lyco-CNPs) optimized for enhanced stability and drug delivery (diameter: 163 ± 6 nm; zeta potential: −9.3 mV), addressing limitations of prior formulations. Key structural and mechanical properties included a fiber diameter of 251 ± 22 nm, tensile strength of 5.86 ± 0.98 MPa, Young's modulus of 1.68 ± 0.25 MPa, and pore diameter of 21.8 nm, ensuring robustness and nutrient diffusion. In vitro studies confirmed a dose-dependent increase in Schwann cell proliferation via MTT assay with the addition of lycopene nanoparticles (NL). In a 10-mm sciatic nerve defect model in rats, the PLGA-CNT-nanoLyco conduit seeded with SCs demonstrated superior regeneration, evidenced by 35.31% higher myelinated nerve density compared to controls. Histopathological (hematoxylin–eosin/Luxol fast blue) and walking-footprint analysis confirmed enhanced axonal alignment and remyelination. These results highlight the conduit's dual functionality as a structural scaffold and bioactive delivery system for nerve repair.
期刊介绍:
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is a highly interdisciplinary peer-reviewed journal serving the needs of biomaterials professionals who design, develop, produce and apply biomaterials and medical devices. It has the common focus of biomaterials applied to the human body and covers all disciplines where medical devices are used. Papers are published on biomaterials related to medical device development and manufacture, degradation in the body, nano- and biomimetic- biomaterials interactions, mechanics of biomaterials, implant retrieval and analysis, tissue-biomaterial surface interactions, wound healing, infection, drug delivery, standards and regulation of devices, animal and pre-clinical studies of biomaterials and medical devices, and tissue-biopolymer-material combination products. Manuscripts are published in one of six formats:
• original research reports
• short research and development reports
• scientific reviews
• current concepts articles
• special reports
• editorials
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is an official journal of the Society for Biomaterials, Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Manuscripts from all countries are invited but must be in English. Authors are not required to be members of the affiliated Societies, but members of these societies are encouraged to submit their work to the journal for consideration.